Key result
Hodgkin lymphoma survivors treated in adolescence or adulthood face high lifelong cardiovascular disease risk.
Answers are grounded in this paper and cite their sources.
Hodgkin Lymphoma survivors face a persistently increased risk of cardiovascular disease throughout their lives, necessitating awareness from physicians and patients.
Throughout their lives, HL survivors treated at adolescence or adulthood are at high risk for various cardiovascular diseases. Physicians and patients should be aware of this persistently increased risk.
No takes yet. Share an insight, caveat, or question.
Nimwegen et al. (2015) studied this question. Hodgkin Lymphoma survivors treated during adolescence or adulthood are at high risk for cardiovascular diseases throughout their lives.
Synapse has enriched 10 related papers. Consider them for comparative context: